bioRxivBiochemistryPreprint
Stereoselective Degradation of Diacylglycerol Kinases Potentiate T cell Activation and Tumor Cell Cytotoxicity
Minhaj Shaikh, Surya Pravo Mookherjee, Claire C. WeckerlyiD, Adam H. Libby, Aizhen Xiao, Yunge ZhaoiD, Sagar D. Vaidya, AeRyon KimiD, Zhihong LiiD, Madeleine L. Ware, Michelle Marants, Olivia L. MurtaghiD, 5, Timothy N. J. BullockiD, Benjamin W. PurowiD, Gerald R. V. HammondiD, Ku-Lung Hsu
Abstract
Stereoselective recognition is a powerful means to differentiate selective versus non-specific activity of small molecules in complex biological systems. Here, we disclose stereochemically defined, sulfonyl-triazole inhibitors of the lipid enzyme diacylglycerol kinase-alpha (DGK), a key metabolic checkpoint for T cell effector function. Acute treatment with the covalent DGK inhibitor AHL-7160 recruited endogenous DGK to the plasma membrane in a stereoselective and isozyme-specific manner. The membrane translocation activity of AHL-7160 correlated with blockade of cellular phosphatidic acid production and potentiation of primary T cell-mediated killing of a glioblastoma cell line. Quantitative chemoproteomics revealed Y669 and K411 as sites of AHL-7160 modification on endogenous DGK in cells. Extended treatments resulted in proteasome-dependent and proteome-wide selective degradation of DGK in T cells. Collectively, these findings establish covalent DGK ligands as potent molecular glues with translational potential in immunotherapy.
- organism: human
- assay: proteomics
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DOK1 and DOK2 regulate CD8+ T cell signaling and memory formation without affecting tumor cell killing
V. Laletin, P.-L. Bernard, … J. Nunes·bioRxiv·Dec 17, 2021
- LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemia
Jun J Yang, Gisele Nishiguchi, … Marcus M. Fischer·bioRxiv·Jul 3, 2025
- Alpha-ketoglutarate inhibits Regulatory T cell differentiation by coupling lipidome remodelling to mitochondrial metabolism
M. I. Matias, C. S. Yong, … N. Taylor·bioRxiv·Aug 24, 2020
- Reshaping the tumor microenvironment by degrading glycoimmune checkpoints Siglec-7 and -9
Chao Wang, Yingqin Hou, … Peng Wu·bioRxiv·Oct 11, 2024
- Glutarate regulates T cell function and metabolism
E. A. Minogue, P. P. Cunha, … R. S. Johnson·bioRxiv·Oct 20, 2022
- Targeting the CDK4-Cyclin D Complex: A New Generation of Selective Kinase Inhibitors for Cancer Therapy
María Fuentes-Baile, José Antonio Encinar, … Miguel Saceda·bioRxiv·Sep 22, 2026